Millipore Sigma Vibrant Logo

361540 GSK-3β Inhibitor I - CAS 327036-89-5 - Calbiochem

The GSK-3β Inhibitor I, also referenced under CAS 327036-89-5, controls the biological activity of GSK-3β. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: TDZD-8, 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione

Primary Target: Gsk-3β
View Products on Sigmaaldrich.com
361540
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
327036-89-5C₁₀H₁₀N₂SO₂

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
361540-5MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 5 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA thiadiazolidinone (TDZD) analog that acts as a highly selective, non-ATP competitive inhibitor of GSK-3β (IC50 = 2 µM). Inhibits Flt-3 and PKC activities (IC50 = 673 nM and 1.4-5.5 µM, respectively). Does not significantly affect the activities of Cdk-1/cyclin B, CK-II, and PKA, (IC50 > 100 µM). Binds to the active site of GSK-3β.
      Catalogue Number361540
      Brand Family Calbiochem®
      SynonymsTDZD-8, 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
      References
      ReferencesGuzman, M.L., et al. 2007. Blood 110, 4436.
      Barry, F.A., et al. 2003. FEBS Lett. 553, 173.
      Martinez, A., et al. 2002. J. Med. Chem. 45, 1292.
      Product Information
      CAS number327036-89-5
      ATP CompetitiveN
      FormWhite to off-white solid
      Hill FormulaC₁₀H₁₀N₂SO₂
      Chemical formulaC₁₀H₁₀N₂SO₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetGsk-3β
      Primary Target IC<sub>50</sub>2 µM, 673 nM, 1.4-5.5 µM, against GSK-3β, Flt-3, and PKC activities, respectively
      Purity≥ 95% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      361540-5MG 07790788049584

      Documentation

      Required Licenses

      Title
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      GSK-3β Inhibitor I - CAS 327036-89-5 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      GSK-3β Inhibitor I - CAS 327036-89-5 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      361540

      Références bibliographiques

      Aperçu de la référence bibliographique
      Guzman, M.L., et al. 2007. Blood 110, 4436.
      Barry, F.A., et al. 2003. FEBS Lett. 553, 173.
      Martinez, A., et al. 2002. J. Med. Chem. 45, 1292.

      Brochure

      Titre
      Alzheimer's Disease Brochure & Technical Guide
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-April-2011 RFH
      SynonymsTDZD-8, 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
      DescriptionA cell-permeable, thiadiazolidinone (TDZD) analog that acts as a highly selective, non-ATP-competitive inhibitor of GSK-3β (IC50 = 2 µM). Inhibits Flt-3 and PKC activities (IC50 = 673 nM and 1.4-5.5 µM, respectively). Does not significantly affect the activities of Cdk1/cyclin B, CK-II, PKA, or PKC (IC50 >100 µM). Shown to inhibit collagen- and thrombin-induced platelet aggregation.
      FormWhite to off-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number327036-89-5
      Chemical formulaC₁₀H₁₀N₂SO₂
      Structure formulaStructure formula
      Purity≥ 95% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesGuzman, M.L., et al. 2007. Blood 110, 4436.
      Barry, F.A., et al. 2003. FEBS Lett. 553, 173.
      Martinez, A., et al. 2002. J. Med. Chem. 45, 1292.